The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial Results on February 28, 2017
February 17 2017 - 07:00AM
Business Wire
The Medicines Company (NASDAQ:MDCO) will host a conference
call on Tuesday, February 28, 2017, at 8:30 a.m., Eastern Time, to
discuss fourth-quarter and full-year 2016 financial results and
operational developments.
The dial-in information to access the call is listed below:
U.S./Canada: (877) 359-9508International: (224)
357-2393Conference ID: 66296847
A taped replay of the conference call will be available from
11:30 a.m., Eastern Time, following the conference call until 11:30
a.m., Eastern Time, on March 7, 2017. The replay may be accessed as
follows:
U.S./Canada: (855) 859-2056International: (404)
537-3406Conference ID: 66296847
The webcast can be accessed in the Investors section of The
Medicines Company website. A replay of the webcast will also be
available.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by
an overriding purpose — to save lives, alleviate suffering and
contribute to the economics of healthcare. The Company’s mission is
to create transformational solutions to address the most pressing
healthcare needs facing patients, physicians and providers in three
critical therapeutic areas: serious infectious disease care,
cardiovascular care and surgery and perioperative care. The Company
is headquartered in Parsippany, New Jersey, with global innovation
centers in California and Switzerland.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170217005153/en/
The Medicines CompanyMediaMeg
LanganVice President,
973-290-6319margaret.langan@themedco.comorInvestor RelationsKrishna Gorti, M.D.,
973-290-6122Vice President, Investor
Relationskrishna.gorti@themedco.com
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2023 to Mar 2024